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Review on strategies to minimize the appearance of multi-drug resistant               
organism 
Abstract 
Background: The use of antibiotic drugs (ABX) in 
hospitals, and especially in intensive care units 
(ICU), is widespread. The early administration of 
ABX therapy can improve survival rates. The     
influence and impact of the ABX are observed in 
the patients who receive them (clinical response, 
course) and in the ecosystem surrounding the    
patient (hospital flora). 
Aim of the review: The objective of this review is 
to identify strategies that reduce or limit the      
appearance and transmission of                           
multidrug-resistant microorganisms. This identifi-
cation can then develop a rational use of the ABX 
plan in the ICU. 
Method: The following databases were queried; 
Medline, Embase, The Cochrane Library, and the 
Centre for Reviews and Dissemination (University 
of York), asking the questions in PICO format to 
evaluate the efficacy and safety of several inter-
ventions: A) Therapeutic de-escalation; B) Cycling 
of ABX and; C) Early antibiotic treatment. 
Results: A) In therapeutic de-escalation of 98 
studies identified, three studies that met the         
inclusion criteria were analyzed. B) Two studies 
comparing antibiotic cycling versus other inter-
ventions were selected. C) No studies have been 
found with sufficiently robust methodological      
designs that address the ABX early treatment. 
There is no strong evidence to indicate which of 
the different antibiotic interventions (therapeutic 
de-escalation, cycling of ABX and preemptive 
treatment) is more effective in reducing antibiotic 
resistance in ICU patients. There is insufficient 
evidence that de-escalation of antimicrobial 
agents is effective against resistance. In patients 
admitted to the ICU with a low prevalence of   
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fluoroquinolones resistance, increased       
exposure to this class of antibiotics, using 
antibiotic cycling,     increases the            
emergence of resistant strains. 
Conclusion: Despite the fact that no          
prospective studies were identified in this 
SR, rationale and day-to-day clinical prac-
tice experience suggest that                         
multidisciplinary participation of different 
specialists in ABX's Infection and Policy 
Commission (or the ABX Commission), or 
the Pharmacy and Therapeutics               
Committee, might improve the develop-
ment and application of these strategies. 
Keywords:  Drug resistance, Cross              
infection, Anti-bacterial agents, Intensive 
care units  
 
Introduction  
The use of antibiotic drugs (ABX) in          
hospitals, and especially in intensive care 
units (ICU), is widespread. The early          
administration of ABX therapy can              
improve survival rates (Mok et al., 2014). 
The influence and impact of the ABX are 
observed in the patients who receive them 
(clinical response, course) and in the        
ecosystem surrounding the patient 
(hospital flora). This impact is especially 
visible in the critically ill patients in the 
endemic flora of the ICU (Alvarez Lerma et 
al., 2010). 
 
Treatment with broad-spectrum ABX is 
generally used for early treatment, since it 
has been shown that preemptive             
treatment, with the appropriate ABX,         
reduced mortality rates. This approach 
may expose individuals to excessive use of 
ABX and therefore, the selection of re-
sistance to these pathogens (Silva et al., 
2013).The        European Centre for Disease 
Prevention and Control (ECDC) and the 
European Medicines Agency (EMA)               
estimated that each year 25,000 Europeans 
die as a direct consequence of a multidrug-
resistant    infection (ECDC/EMA, 2009). 
 
In Spain, as some projects in other              
European Member States (e.g. the          
Netherlands (Schuts et al., 2016)), the         
National Action Plan on Antimicrobial    
Resistance (AEMPS, 2018) was nationally 
coordinated in 2014 by the Spanish Agency 
of Medicines and Medical Devices,             
together with six    Ministries, with the        
objective of   minimizing the  impact of     
antimicrobial     resistance and how to be 
addressed jointly from the human and    
veterinary health. The importance of the 
ABX as part of the pharmacotherapy             
arsenal is unquestionable, hence the              
importance of improving the management 
of the knowledge about them.  
 
Health and social care practitioners have to 
make clinical  decisions daily.   Compatible 
update of knowledge and health care is a                 
complicated task, and Clinical Practice 
Guidelines (CPG) are useful tools to              
facilitate decision-making. Initiatives such 
as the Program for Optimizing the use of 
Antimicrobials (PROA) in Spanish                
hospitals (Rodriguez-Bano et al., 2012) can 
contribute to improve policy of ABX, and 
minimize the emergence of resistance in 
microorganisms. Within the framework of 
the ICU it emphasizes the "Zero resistance" 
programme (Garnacho Montero et al., 
2015). 
One of the lines of work, typically               
proposals from hospital pharmacy services, 
is the sequential therapy, but there are        
interventions whose evidence is not proven 
and that should be evaluated. These                  
include the therapeutic de-escalation, and 
cycling of ABX and preemptive treatment. 
The objective of this review is to                      
identify strategies that reduce or limit the 
appearance and cross transmission of             
multidrug-resistant organisms in order to 
make rational use of the ABX. 
 
Data and Methods: 
Strategies to minimize the emergence of 
multidrug-resistant organisms in ICU with 
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Therapeutic de-escalation, B) Cycling of 
ABX, and C) Early antibiotic treatment. 
Other strategies, to reduce cross                          
transmission of multidrug-resistant                 
organisms in ICU, are also addressed, such 
us: 1) preventive isolation or 2)                                           
active   surveillance for patients in the early 
identification of Methicillin-resistant                                
Staphylococcus aureus (MRSA) on                           
asymptomatic carriers of other                               
multidrug-resistant microorganisms. 
Therefore, this review is focused to identify 
interventions that might help to prevent 
resistance to antimicrobials, in the hospital 
and ICU, to reduce morbidity and                     
mortality by antimicrobial-resistant                
organisms. 
The following databases were searched           
until January 2018: Medline (via PubMed), 
Embase, The Cochrane Library and the 
Centre for Reviews and Dissemination, and 
University of York. We used the controlled 
vocabulary thesaurus (MeSH or Emtree), 
used for indexing articles for PubMed, 
Cochrane and CRD (MeSH) or Embase 
(Emtree), as appropriate, as well as                    
searching by free language terms for each 
construct of the research question,         
disaggregated in its PICO form (Patient, 
Intervention, Comparison, and Outcome). 
Comprehensive and updated (2008-2018) 
search strategies, including comprehensive 
search terms (i.e. resistance antibiotic AND 
intensive care unit). The literature search,
(can be found in the supplementary       
material, which is available to authorized 
users) with the ATC classification group J01 
(WHO, 2017), is described in the flow          
diagram in Figure 1. The results were also 
accompanied by a manual search on          
UpToDate® (Waltman, MA) and grey                 
literature findings. 
Inclusion and exclusion criteria were estab-
lished a priori. We have included studies, 
which related interventions allowing                 
estimators or comparative information on 
reduction, elimination of the appearance, 
or cross transmission of multidrug-
resistant microorganisms to ABX. Studies 
reporting interventions on reducing         
resistance levels, for various classes of         
antibiotics, such as aminoglycosides or 
quinolones, were excluded. 
Systematic reviews (SR) that do not                  
provide quantitative data on the results of 
the interventions of interest and articles 
without abstract were excluded. It is used 
as filter design studies, selecting those 
which are clinical practice guidelines 
(CPG), randomized clinical trials (RCT), 
and economic evaluation studies. 
 
Results 
A) De-escalation therapy 
Of 98 identified studies, we have analyzed 
3 studies that met the criteria of inclusion: 
1 SR (Silva et al., 2013), 1 RCT (Kim et al., 
2012), and 1 CPG (Dellinger et al., 2013). 
The SR, despite identifying several studies, 
discards them for being uninteresting              
interventions or clinical conditions not   
relevant to the review. 
The study done by Kim et al., 2012 shows 
statistically significant differences in favour 
of de-escalation in terms of the adequacy 
of the ABX and against the de-escalation in 
the time of occurrence of multi-drug              
resistant organism, primarily due to MRSA; 
HR = 3.84 (95% CI: 1.06; 13.9). Mortality, 
duration of the ABX, stay in ICU or adverse 
treatment, showed no statistically                       
significant differences. Dellinger et al., 2013 
were advised to follow the principles of the 
Grading of  Recommendations Assessment,                         
Development and Evaluation (GRADE)  
system to guide assessment of quality of 
evidence, and include in the international 
CPG: 1) the need to identify pathogens and 
apply more efficient ABX treatment, 2)    
reduction of the spectrum of antibiotic 
coverage, and 3) the reduction of the          
duration of the ABX treatment.  
This  decreases the chances that the               
patient develops infections by                              
multi-resistant pathogens and the             





Frutos Pérez-Surio . 2018 
144 
Volume 2 Issue 3, July  2018  
treatment ABX to increase the effectiveness 
of the treatment and improve health        
outcomes. 
 
B) Cycling of ABX 
Two studies were selected (Nijssen et al., 
2010; Martinez et al., 2006) that compare 
ABX cycling to other interventions. The 
first, a period of cycling's three months, 
gets 14 crops with Enterobacteriaceae       
resistant to third generation                     
cephalosporin’s (3GCRE) for every 1,000 
patients per day to risk. This data is the 
same as during the baseline period,         
observation of the ICU. During the three 
months of not cycling (reducing exposure 
to beta-lactams and introduction of            
fluoroquinolones), there are 18 crops with 
(CPG) for every 1,000 patients per day to 
risk. During the three months of cycling, 
isolated 2.5 (CPG) resistant to                       
fluoroquinolones (FRE) for every 1,000           
patients per day to risk, being the similar        
results of the baseline period (2.1 FRE 1,000 
patients day to risk) in contrast with the 
period of not cycling, which they have 8.3 
FRE for every 1,000 patients per day at risk 
(Nijssen et al., 2010).  
 
When the explanatory model is adjusted by 
type of ICU, age of the patient,                     
gravity - APACHE II, indication of               
admission, and reason of contacts, not          
cycling for 3 months in ICU (reduction of 
beta-lactam and introduction of                    
fluoroquinolones), increases the speed of 
appearance of FRE in 4.1 times with regard 
to the cycling of ABX (adjusted HR = 4.1 
[95% CI: 1.4; 11.9]) (Nijssen et al., 2010). The 
Group of   Martinez et al. (2006) analyzed 
along 8 months, in two ICU, a pattern of 
cycling of ABX with another mixed pattern 
that was administered to  patients, as they 
enter consecutively to analyze the                            
emergence of resistance in gram-negative 
enteric Bacilli.  
 
They found that the prevalence of                      
resistance acquired during two periods of 
study was highest during the mixed period 
than during the period of cycling (9% vs. 
3% respectively, p = 0.01) for Pseudomonas 
aeruginosa and specifically, for cefepime. 
No statistically significant differences for 
other bacilli can be seen on                                  
Enterobacteriaceae (Martinez et al., 2006). 
 
C) Preemptive treatment 
No studies have been found with robust 
enough methodological designs that         
address the preemptive treatment. Study 
designs were not enable to provide robust 
evidence about preemptive treatment (De 
Waele et al., 2003; Piarroux et al., 2004). 
 
Cross transmission 
We found 5 studies, of which 3 are SR (Lam 
et al., 2012; Pammi et al., 2011; Backman et 
al., 2008) and 2 RCT (Huang et al., 2013; 
Climo et al., 2013). A SR evaluates the  
effectiveness of the measures of oral         
hygiene in reducing colonization of                     
Staphylococcus aureus (Lam et al., 2012) 
and given that only 3 of the 15 studies          
included in the review had been done with 
ICU patients with mechanical ventilation 
(MV), results of the three studies were            
displayed (Pedreira et al. 2009;                      
Scannapieco et al., 2009; Fourrier et al., 
2000) with broader objectives.  
In all three studies, part of the intervention 
consists of performing oral hygiene with 
chlorhexidine in critically ill patients with 
MV. Results from the Paediatric ICU show 
no difference on colonization of                     
oropharyngeal, duration of the MV, length 
of stay in ICU, or isolation of                  
multidrug-resistant bacteria (Pedreira et al. 
2009). A second study with adult patients 
showed a significant reduction in the  
number of isolates by culture                         
Staphylococcus aureus versus placebo at 2 
and 4 days of admission to ICU with MV. 
There was no statistically significant            
difference in the occurrence of pneumonia, 
or it has been observed that interventions 





Frutos Pérez-Surio . 2018 
145 
Volume 2, Issue 3, July 2018  
(Scannapieco et al., 2009).  
The work done in France excludes study to 
toothless patients and select patients with 
exclusively medical processes all with MV. 
Oral isotonic serum bicarbonate and              
oropharyngeal suction cleaning 4 times a 
day improve in a statistically significant 
way to more nosocomial infection (NI) that 
the application of gel with chlorhexidine 
associated with 0.2% in teeth and gums 
with sterile glove 3 times daily (p = 0.018). 
The application of chlorhexidine is also as-
sociated with a reduction in the number of 
ventilation-associated pneumonia (VAP) (p 
< 0.05) (Fourrier et al., 2000). 
The SR of Pammi et al. 2011 sought to              
analyze the effect of isolation measures in 
reducing the cross transmission of Candida 
from infants colonized or infected. No            
evidence was found supporting or not of 
isolation measures, both individually and 
in group, in ICU of infants (Pammi et al., 
2011). 
A SR identified which aims to evaluate the 
relationship between hand hygiene                
interventions and the incidence of NI 
(Backman et al., 2008). In addition to 35 
studies, one included is a RCT in Paediatric 
ICU selected (except kidney) solid organ 
transplant patients. Observed hand      
washing with chlorhexidine before and         
after each patient contact or the use of 
robe and latex gloves non sterile with each 
patient contact, reduce the incidence of NI 
ICU in a statistically significant way         
between the previous year and the 6 
months after the interventions (4.9/100 
days vs. 2.2/100); p = 0.0004. Statistically 
significant differences were not found in NI 
average in transplanted between groups 
(Slota et al., 2001). 
Work done with 74 ICU adults in the           
United States, included 74,256 patients and 
compared between different interventions 
(screening and isolation, specific                     
decolonization and universal                           
decolonization) to reduce the transmission 
of MRSA and other pathogens acquired in 
ICU. To compare interventions with the 
baseline period (prior to the                            
implementation of interventions), a        
statistically significant reduction is           
observed of positive cultures for MRSA           
acquired in ICU (p = 0.01), as well as                   
bacteraemia caused by others pathogens 
acquired in ICU (p <; 0.001). Statistically 
significant differences for bacteraemia by 
MRSA acquired in ICU are not observed 
both to compare between periods and            
between groups. Comparing between 
groups, universal decolonization was the 
intervention that reduced the occurrence 
of positive cultures for MRSA and ICU-
acquired bacteraemia by other pathogens 
more effectively (Huang et al., 2013). 
A multicenter RCT, with the participation 
of 9 ICU (a total of 7,727 patients) assessed 
the utility of body hygiene through            
cleaning wipes, with chlorhexidine          
gluconate 2%, to reduce the risk of                
acquiring multiresistant organisms and 
bacteraemia nosocomial in critically ill            
patients. The  duration of the intervention 
period     decreased, in a statistically       
significant way, a 23% NI MRSA and          
Vancomycin-resistant Enterococcus (VRE), 
a 28% nosocomial bacteraemia, 31%          
primary bacteraemia, and 53%                          
bacteraemia, associated to central    venous 
catheter. A reduction of 90% of fungaemia 
is also described, associated with central 
venous catheter (Climo et al., 2013). 
Antimicrobial stewardship guidelines and 
initiatives previously published by the            
Infectious Disease Society of America 
(IDSA), e.g. IDSA and Society for 
Healthcare Epidemiology of America 
(SHEA) jointly published Guidelines for 
Developing an Institutional Program to   
Enhance Antimicrobial Stewardship, in 
Clinical Infectious Diseases (January 2007 
vol. 44 no. 2 159-177) for developing            
institutional programs to enhance antimi-
crobial stewardship, an activity that          
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route, and     duration of antimicrobial 
therapy. A brief summary related to 
"Infections and antimicrobial                      
resistance in the intensive care unit:         
Epidemiology and prevention", found on 
UpToDate®, is adapted with  permission on 
table 1: Summary of                                            
recommendations for preventing ventilator




Studies of quality capable of sustaining            
analyzed ABX policy measures have been 
searched and identified. It would be        
necessary to design prospective research 
studies that can establish a causal                     
relationship between the policy measures 
of ABX and the emergence of                            
multidrug-resistant organisms in ICUs            
reduction. Studies with more robust             
designs that allow you to determine if oral 
hygiene in critically ill patients with MV's 
more 48 hours has a clinically relevant          
impact is required. As antimicrobial                 
stewardship Pharmacist, you can make 
prospective audit and feedback, if you         
review the information and recommend 
that the prescribing team narrow therapy.  
Antibiotics should be discontinued within 
48 hours after surgery. It is necessary to 
carry out studies that allow determining 
the clinical impact of the role of isolation 
measures in patients, colonized or infected 
by Candida. There is no doubt of the                
importance of interventions to improve 
hand hygiene to reduce the incidence of NI 
in critically ill patients. Universal              
decolonization in critically ill patients         
reduce bacteraemia, prevents the                     
realization of surveillance test, reduces the                
number of isolates of contact, and           
decreases the chances of transmission of 
infection to other patients. The personal 
hygiene of critically ill patients with                  
chlorhexidine-impregnated wipes reduces 
the transmission of bacteria resistant to 
other patients. 
Therapeutic de-escalation consists in               
initiating ABX therapy with                           
broad-spectrum empirical therapy, with 
the aim of increasing the chances of               
covering the probable infectious agent.                    
Subsequently, a broad spectrum treatment 
change is performed. De-escalation should 
occur with respect to culture data or             
clinical judgment. Empiric use of             
combination therapy should not be             
administered for longer than 3-5 days if                 
de-escalation to a single agent is                      
appropriate. Empiric antimicrobials should 
cover likely pathogens according to                       
suspected location of infection and risk of 
multidrug-resistant pathogens. Other            
considerations in choosing appropriate  
antimicrobials include the patient’s history 
of drug allergy or intolerance, recent               
antibiotic use, comorbidities, and                          
antimicrobial susceptibility patterns in the 
community and hospital. Consider                    
discontinuing antimicrobials in 7-10 days 
unless there is slow response, undrainable                  
foci, immunosuppression, or multidrug-
resistant pathogens.  
Blood cultures will be negative in most          
patients, despite a bacterial of fungal origin 
of sepsis. Clinical judgment is needed when 
considering discontinuation of                           
antimicrobials. According to the results of 
the microbiological studies, a treatment 
with a more adjusted antimicrobial               
spectrum by one of the following two    
pathways: 1) change of ABX, and;                         
2) Interrupt an antibiotic combination. An 
additional strategy to shorten the duration 
of ABX treatment (Alvarez Lerma et al., 
2010; Silva et al., 2013). Crop performance is 
a prerequisite for the use of antibiotic       
de-escalation in critically ill patients,           
although the decision to reduce the              
intensity of treatment should be based on 
the patient's clinical course (Silva et al., 
2013). Therapeutic de-escalation aims to 
achieve adequate antibiotic coverage 
through the use of ABX in a targeted             
manner, reducing the spectrum of                   
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pressure on the patient's flora as well as the 
ecosystem in which the latter remains. 
The cycling of ABX consists of the                   
determined alternation of ABX by which 
the use of an ABX or specific ABX class is 
restricted for a certain period of time to be 
reintroduced subsequently (Sandiumenge 
et al., 2003). Other authors describe cycling 
as the periodic substitution of one class of 
ABX by another class or the combination of 
ABX that present a spectrum of similar            
activity, but do not share the same                 
mechanism of resistance (Alvarez Lerma et 
al., 2010). It is intended to minimize the 
occurrence of bacterial resistance to the 
ABX in use, reducing the selective pressure 
exerted on the microbial flora 
(Sandiumenge et al., 2003). 
Preemptive treatment is the administration 
of ABX in some patients before clinical 
signs of infection appear. The application 
of this concept to critically ill patients is 
based on the identification of patients at 
risk of infections associated with high  
mortality, such as systemic fungal               
infections (Alvarez Lerma et al., 2010). 
Having information on the quality of             
antibiotic prescription can help identify 
problems and implement strategies to           
improve this prescription; the European 
Surveillance of Antimicrobial Consumption 
(ESAC) has developed a group of indicators 
of antibiotic use in outpatients with the 
objective to measure the quality of the use 
of antibiotics and thus improve their use 
(Coenen et al., 2007). 
Conclusion 
Despite the fact that no prospective studies 
were identified in this SR, rationale and 
day-to-day clinical practice experience sug-
gest that multidisciplinary participation of 
different specialists in ABX's Infection and 
Policy Commission (or the ABX                 
Commission), or the Pharmacy and Thera-
peutics Committee, might improve the                
development and application of these 
strategies.  
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From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for 






Records identified through database 
searching 
































Additional records identified 
through other sources 
(n = 28) 
Records after duplicates removed 
(n = 5 611) 
Records screened 
(n = 1346 ) 
Records excluded 
(n =  1 239 ) 
Full-text articles as-
sessed for eligibility 
Full-text articles exclud-
ed, with reasons 
Studies included in qual-
itative synthesis 
Medline/Pubmed – 4 133 
EMBASE – 1 292 
Cochrane – 48 
CRD – 252 
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Recommendation Rationale Intervention Quality of         
evidence 
Basic practices Good evidence that the inter-
vention decreases the average 
duration of mechanical ventila-
tion, length of stay, mortality, 
and/or costs; benefits likely 
outweigh risks 
Use noninvasive positive pressure ventilation in se-
lected populations 
High 
Manage patients without sedation whenever possible Moderate 
Interrupt sedation daily High 
Assess readiness to extubate daily High 
Perform spontaneous breathing trials with sedatives 
turned off 
High 
Facilitate early mobility Moderate 
Utilize endotracheal tubes with subglottic secretion 
drainage ports for patients expected to require greater 
than 48 or 72 hours of mechanical ventilation 
Moderate 
Change the ventilator circuit only if visibly soiled or 
malfunctioning 
High 
Elevate the head of the bed to 30 to 45° Low* 
Special                    
approaches 
Good evidence that the inter-
vention improves outcomes but 
insufficient data available on 
possible risks 
Selective oral or digestive decontamination High¶ 
May lower VAP rates but insuffi-
cient data to determine impact 
on duration of mechanical ven-
tilation, length of stay, or mor-
tality 
Regular oral care with chlorhexidine Moderate 
Prophylactic probiotics Moderate 
Ultrathin polyurethane endotracheal tube cuffs Low 
Automated control of endotracheal tube cuff                
pressure 
Low 
Saline instillation before tracheal suctioning Low 
Mechanical tooth brushing Low 
Generally not recom-
mended 
Lowers VAP rates but ample 
data suggest no impact on dura-
tion of mechanical ventilation, 
length of stay, or mortality 
Silver-coated endotracheal tubes Moderate 
Kinetic beds Moderate 
Prone positioning Moderate 
No impact on VAP rates, average 
duration of mechanical ventila-
tion, length of stay, or mortali-
tyΔ 
Stress ulcer prophylaxis Moderate 
Early tracheotomy High 
Monitoring residual gastric volumes Moderate 
Early parenteral nutrition Moderate 
No recommendation No impact on VAP rates or other 
patient outcomes, unclear im-
pact on costs 
Closed/in-line endotracheal suctioning Moderate 
Table 1. Summary of recommendations for preventing ventilator-associated pneumonia (VAP) in 
adult patients — Society for Healthcare Epidemiology of America/Infectious Diseases Society of 
America (SHEA/IDSA) 
* There are very little data on head-of-bed elevation, but it is classified as a basic practice because of its simplicity, ubiquity, low cost, 
and potential benefit. 
¶ There are abundant data on the benefits of digestive decontamination but insufficient data on the long-term impact of this strategy 
on antimicrobial resistance rates. 
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